» Articles » PMID: 24395080

Complications and Survival Associated with Operative Procedures in Patients with Unresectable Pancreatic Head Adenocarcinoma

Overview
Journal J Surg Oncol
Date 2014 Jan 8
PMID 24395080
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Unresectable tumors of the pancreatic head are encountered in up to 20% of patients taken for resection. The objective of this study was to evaluate the complications and outcome associated with palliative surgical procedures to help guide management decisions in these patients.

Methods: Patients with pancreatic head adenocarcinoma taken to the operating room with curative intent who did not undergo pancreatectomy were evaluated.

Results: From 1997 to 2013, 50 patients were explored and found be unresectable due to M1 disease (n = 27, 54.0%) or vascular invasion (n = 23, 46.0%). Among unresectable patients, 34 (68.0%) had a palliative procedure performed including double bypass (n = 13), biliary bypass (n = 7), gastrojejunostomy (n = 5), or cholecystectomy (n = 9). Complications occurred in 22 patients (44.0%), and patients who had a palliative operation had a longer hospital stay and more major complications. Overall survival was reduced in patients treated with a palliative operation.

Conclusions: Despite advancements in endoscopic palliation, operative bypasses are still commonplace in patients with unresectable pancreatic head cancer. In this study, patients treated with operative procedures had a high rate of complications without a notable improvement in outcome. These findings highlight the importance of identifying unresectable disease prior to surgery and support a selective approach to palliative operations.

Citing Articles

Outcomes and risks in palliative pancreatic surgery: an analysis of the German StuDoQ|Pancreas registry.

Hofmann F, Miksch R, Weniger M, Keck T, Anthuber M, Witzigmann H BMC Surg. 2022; 22(1):389.

PMID: 36368993 PMC: 9652845. DOI: 10.1186/s12893-022-01833-3.


Surgical exploration without resection in pancreatic and periampullary tumors: Report from a national database.

Sahlstrom E, Nilsson J, Tingstedt B, Bergenfeldt M, Andersson R, Andersson B Scand J Surg. 2020; 110(3):344-350.

PMID: 32299289 PMC: 8551431. DOI: 10.1177/1457496920913669.


Palliative bypass surgery for patients with advanced pancreatic adenocarcinoma: experience from a tertiary center.

Pencovich N, Orbach L, Lessing Y, Elazar A, Barnes S, Berman P World J Surg Oncol. 2020; 18(1):63.

PMID: 32238149 PMC: 7114792. DOI: 10.1186/s12957-020-01828-5.


A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score.

Maulat C, Canivet C, Touraine C, Gourgou S, Napoleon B, Palazzo L Cancers (Basel). 2020; 12(4).

PMID: 32218346 PMC: 7226323. DOI: 10.3390/cancers12040783.


Outcomes of endoscopic ultrasound-guided biliary drainage: A systematic review and meta-analysis.

Hedjoudje A, Sportes A, Grabar S, Zhang A, Koch S, Vuitton L United European Gastroenterol J. 2019; 7(1):60-68.

PMID: 30788117 PMC: 6374841. DOI: 10.1177/2050640618808147.